(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...

Most people notice this when air pressure changes rapidly, such as when a plane ascends or descends. This happens because the pressurization of the cabin isn't perfect, and the ear pressure is higher ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...

Since the pandemic, health officials have approved new vaccines to help Americans combat severe symptoms from COVID-19, respiratory syncytial virus, or RSV, and influenza. Experts urge eligible ...

The good news is that even as cases rise and will likely continue to, new as well as tried and true vaccines are available to target COVID-19, influenza and respiratory syncytial virus ...

“Make a plan now for you and your family to get both updated flu and COVID vaccines this fall, ahead of the respiratory virus season.” Here’s what to know about the vaccines available to protect ...

Respiratory syncytial virus is a common infection of the lungs ... breakthroughs made in the United States to understand the structure of the RSV virus’s fusion protein used to invade cells ...